Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tegeline in DRESS Syndrome
NCT00505648Phase 3Terminated
- Sponsor
- Rouen University Hospital
- Start
- Jan 2008
- Primary completion
- Jun 2010
- Modality
- Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of polyvalent human immunoglobulin in Drug Reaction with Eosinophilia and Systemic Symptoms syndrome (DRESS), sponsored by Rouen University Hospital. Started Jan 2008; status: terminated.
02
Drugs
polyvalent human immunoglobulin
03
Conditions
Drug Reaction with Eosinophilia and Systemic Symptoms syndrome (DRESS)
Beyond the preview
Go deeper on NCT00505648.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00505648.